Kubo, Masayuki
Matsumoto, Masanori http://orcid.org/0000-0002-7243-3126
Article History
Received: 15 December 2022
Revised: 25 January 2023
Accepted: 25 January 2023
First Online: 9 February 2023
Declarations
:
: MM is an inventor of the ELISA used to assess ADAMTS13 activity and has received research funds from Chugai Pharmaceutical and lecture fees from Sanofi, Alexion Pharmaceuticals, and Takeda Pharmaceutical. MK has no conflicts of interest.